Predictive value of PD-L1 expression and dMMR/pMMR status for immune checkpoint inhibitor combined with chemotherapy in advanced/recurrent endometrial cancer: a meta-analysis.
메타분석
1/5 보강
OpenAlex 토픽 ·
Endometrial and Cervical Cancer Treatments
Cancer Immunotherapy and Biomarkers
Ferroptosis and cancer prognosis
APA
Lifang Lan, Zhuangyan Tang, et al. (2026). Predictive value of PD-L1 expression and dMMR/pMMR status for immune checkpoint inhibitor combined with chemotherapy in advanced/recurrent endometrial cancer: a meta-analysis.. World journal of surgical oncology. https://doi.org/10.1186/s12957-026-04330-6
MLA
Lifang Lan, et al.. "Predictive value of PD-L1 expression and dMMR/pMMR status for immune checkpoint inhibitor combined with chemotherapy in advanced/recurrent endometrial cancer: a meta-analysis.." World journal of surgical oncology, 2026.
PMID
41992277
같은 제1저자의 인용 많은 논문 (3)
- A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells.
- Epigenetic Suppression of Histone Deacetylase 4 Boosts T Cell Homing via CXCR3 in Lung Cancer: A Step Toward Ultrasound-Guided Immunotherapy.
- Botulinum Toxin-Based Study: Histological Changes in the Rabbit Vocal Folds and Construction of the Voice Rest Model With Different Rest Durations.